BSE Live
Oct 03, 16:01Prev. Close
207.50
Open Price
206.50
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 03, 15:53Prev. Close
207.05
Open Price
208.79
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
Cash Flow of Suven Life Sciences (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
Net Profit/Loss Before Extraordinary Items And Tax | -47.08 | -9.01 | -20.13 | -36.25 | -27.95 | |
Net CashFlow From Operating Activities | -47.39 | -20.56 | -10.09 | -36.62 | -36.68 | |
Net Cash Used In Investing Activities | 44.21 | -0.68 | -361.66 | -107.46 | 2.41 | |
Net Cash Used From Financing Activities | -0.76 | -1.05 | 395.54 | 145.69 | 34.86 | |
Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Net Inc/Dec In Cash And Cash Equivalents | -3.94 | -22.30 | 23.79 | 1.61 | 0.58 | |
Cash And Cash Equivalents Begin of Year | 4.40 | 26.70 | 2.90 | 1.29 | 0.71 | |
Cash And Cash Equivalents End Of Year | 0.46 | 4.40 | 26.70 | 2.90 | 1.29 |
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y
27.01.2025
Suven Life Sci Standalone December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y
08.01.2025
Suven Life shares rise 11% on progress in clinical trial of cognitive disorder drug
13.05.2025
Suven Life Sci Standalone March 2025 Net Sales at Rs 1.47 crore, down 38.5% Y-o-Y
28.01.2025
Suven Life Sci Consolidated December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y
27.01.2025
Suven Life Sci Standalone December 2024 Net Sales at Rs 1.61 crore, down 34.31% Y-o-Y
30.10.2024
Suven Life Sci Consolidated September 2024 Net Sales at Rs 2.57 crore, down 15.91% Y-o-Y